newsfilter
← Latest News
Business Wire·

Merrimack Reports First Quarter 2022 Financial Results

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) [("Merrimack" or the "Company")] today announced its first quarter 2022 financial results for the period ended March 31, 2022. "During the first quarter of 2022 we continued to see reductions in our opera